Advertisement

Non-typhoidal Salmonella in Children: Microbiology, Epidemiology and Treatment

  • Gabrielle M. Haeusler
  • Nigel CurtisEmail author
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 764)

Abstract

Non-typhoidal Salmonellae (NTS) are an important cause of infectious diarrhoea world-wide. In the absence of immune deficiency, gastroenteritis caused by NTS is usually mild, self limiting and rarely requires intervention. NTS are also an important cause of invasive disease, particularly in developing countries, likely secondary to the high prevalence of co-existing malnutrition, malaria and HIV infection. This review provides an overview of the microbiology, epidemiology and pathogenesis of NTS, and compares recommendations for the treatment of NTS gastroenteritis in children.

Keywords

Hand Hygiene Nalidixic Acid Chronic Granulomatous Disease Invasive Disease Acute Gastroenteritis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Grimont PAD, Weill F (2007) Antigenic Formulae of the Salmonella Serovars. 9th edn. Institut Pasteur, ParisGoogle Scholar
  2. 2.
    Tindall BJ, Grimont PAD, Garrity GM, Euzeby JP (2005) Nomenclature and taxonomy of the genus Salmonella. Int J Syst Evol Microbiol 55:521–524PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Nataro JP, Bopp CA, Fields PI, Kaper JB, Strockbine NA (2011) Escherichia, Shigella, and Salmonella. In: Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW (eds). Manual of Clinical Microbiology, 10th edn. ASM, Washington, DC, p 603–626Google Scholar
  4. 4.
    Pegues DA, Miller SI (2010) Salmonella Species, including Salmonella Typhi. In: Mandell GL, Bennett JE, Dolin R (eds). Mandell, Douglas and Bennett’s Principles and Practices of Infectious Diseases, 7th edn. Elsevier, Philadelphia, p 2887–2903CrossRefGoogle Scholar
  5. 5.
    Brenner FW, Villar RG, Angulo FJ, Tauxe R, Swaminathan B (2000) Salmonella nomenclature. J Clin Microbiol 38:2465–2467PubMedPubMedCentralGoogle Scholar
  6. 6.
    Majowicz SE, Musto J, Scallan E, Angulo FJ, Kirk M, O’Brien SJ et al (2010) The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis 50:882–889PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Vieira A, Jensen AR, Pires SM, Karlsmose S, Wegener HC, Wong DLF (2009) WHO Global Foodborne Infections Network Country Databank—a resource to link human and non-human sources of Salmonella. Int Soc Vet Epidemiol Econ 643:512–517Google Scholar
  8. 8.
    Braden CR (2006) Salmonella enterica serotype Enteritidis and eggs: a national epidemic in the United States. Clin Infect Dis 43:512–517PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Hohmann EL (2001) Nontyphoidal salmonellosis. Clin Infect Dis 32:263–269PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Mermin J, Hutwagner L, Vugia D, Shallow S, Daily P, Bender J et al (2004) Reptiles, amphibians, and human Salmonella infection: a population-based, case-control study. Clin Infect Dis 38(Suppl 3):S253–261PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Weikel CS, Guerrant RL (1985) Nosocomial salmonellosis. Infection Control: IC 6:218–220PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    AAP (2006) Salmonella Infections. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS (eds). Red Book: 2009 Report of the Commitee on Infectious Diseases, 28th edn. American Academy of Pediatrics, Elk Grove Village, p 584–588Google Scholar
  13. 13.
    Blaser MJ, Newman LS (1982) A review of human salmonellosis: I. Infective dose. Rev Infect Dis 4:1096–1106Google Scholar
  14. 14.
    Seals JE, Parrott PL, McGowan JE, Jr., Feldman RA (1983) Nursery salmonellosis: delayed recognition due to unusually long incubation period. Infection Control: IC 4:205–208PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Garcia-del Portillo F (2001) Salmonella intracellular proliferation: where, when and how? Microbes Infect 3:1305–311PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Dougan G, John V, Palmer S, Mastroeni P (2011) Immunity to salmonellosis. Immunol Rev 240:196–210PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Gondwea EN, Molyneuxa ME, Goodallc M, Graham SM, Mastroenig P, Draysonc MT et al (2010) Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans. PNAS 107:3070–3075CrossRefGoogle Scholar
  18. 18.
    MacLennan CA, Gondwe EN, Msefula CL, Kingsley RA, Thomson NR, White SA et al (2008) The neglected role of antibody in protection against nontyphoidal salmonella bacteremia in African children. J Clin Invest 118:1553–1562PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Tennant SM, Hartland EL, Phumoonna T, Lyras D, Rood JI, Robins-Browne RM et al (2008) Influence of gastric acid on susceptibility to infection with ingested bacterial pathogens. Infect Immun 76:639–645PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Buchin PJ, Andriole VT, Spiro HM (1980) Salmonella infections and hypochlorhydria. J Clin Gastroenterol 2:133–138PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    O’Ryan ML, Nataro JP, Cleary TG (2011) Microorganisms Responsible for Neonatal Diarrhea. In: Remington JS, Klein JO, Wilson CB, Nizet V, Maldonado Y (eds). Remington: Infectious Diseases of the Fetus and Newborn, 7th edn. Elsevier, Philadelphia, p. 359–418CrossRefGoogle Scholar
  22. 22.
    Moir S, Fauci AS (2010) Immunology. Salmonella susceptibility. Science 328:439–440 (New York, NY)PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Celum CL, Chaisson RE, Rutherford GW, Barnhart JL, Echenberg DF (1987) Incidence of salmonellosis in patients with AIDS. J Infect Dis 156:998–1002PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Ramos JM, Garcia-Corbeira P, Aguado JM, Arjona R, Ales JM, Soriano F (1994) Clinical significance of primary vs. secondary bacteremia due to nontyphoid Salmonella in patients without AIDS. Clin Infect Dis 19:777–780PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Abruzzi A, Fried B (2011) Coinfection of Schistosoma (Trematoda) with bacteria, protozoa and helminths. Adv Parasitol 77:1–85PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Jertborn M, Haglind P, Iwarson S, Svennerholm AM (1990) Estimation of symptomatic and asymptomatic Salmonella infections. Scand J Infect Dis 22:451–455PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Mandal BK, Brennand J (1988) Bacteraemia in salmonellosis: a 15 year retrospective study from a regional infectious diseases unit. BMJ 297:1242–1243 (Clinical research ed)PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Jones TF, Ingram LA, Cieslak PR, Vugia DJ, Tobin-D’Angelo M, Hurd S et al (2008) Salmonellosis outcomes differ substantially by serotype. J Infect Dis 198:109–114PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Vugia DJ, Samuel M, Farley MM, Marcus R, Shiferaw B, Shallow S et al (2004) Invasive Salmonella infections in the United States, FoodNet, 1996–1999: incidence, serotype distribution, and outcome. Clin Infect Dis 38(Suppl 3):S149–156PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Gordon MA (2011) Invasive nontyphoidal Salmonella disease: epidemiology, pathogenesis and diagnosis. Curr Opin Infect Dis 24:484–489PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Graham SM (2010) Nontyphoidal salmonellosis in Africa. Curr Opin Infect Dis 23:409–414PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Scott AJ, Berkley JA, Mwangi I, Ochola L, Uyoga S, Macharia A et al (2011) Relation between falciparum malaria and bacteraemia in Kenyan children: a population–based, case-control study and a longitudinal study. Lancet 378:1316–1323PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Schutze GE, Schutze SE, Kirby RS (1997) Extraintestinal salmonellosis in a children’s hospital. Pediatr Infect Dis J 16:482–485PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Owusu-Ofori A, Scheld WM (2003) Treatment of Salmonella meningitis: two case reports and a review of the literature. Int J Infect Dis 7:53–60PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Sirinavin S, Jayanetra P, Lolekha S, Layangkul T (1988) Predictors for extraintestinal infection in Salmonella enteritis in Thailand. Pediatr Infect Dis J 7:44–48PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Galanakis E, Bitsori M, Maraki S, Giannakopoulou C, Samonis G, Tselentis Y (2007) Invasive non-typhoidal salmonellosis in immunocompetent infants and children. Int J Infect Dis 11:36–39PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Zaidi E, Bachur R, Harper M (1999) Non-typhi Salmonella bacteremia in children. Pediatr Infect Dis J 18:1073–1077PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Katz BZ, Shapiro ED (1986) Predictors of persistently positive blood cultures in children with "occult" Salmonella bacteremia. Pediatr Infect Dis 5:713–714PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    Ramos JM, Aguado JM, Garcia-Corbeira P, Ales JM, Soriano F (1996) Clinical spectrum of urinary tract infections due on nontyphoidal Salmonella species. Clin Infect Dis 23:388–390PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Gasem MH, Keuter M, Dolmans WMV, Van Der Ven-Jongekrijg J, Djokomoeljanto R, Van Der Meer JWM (2003) Persistence of Salmonellae in blood and bone marrow: randomized controlled trial comparing ciprofloxacin and chloramphenicol treatments against enteric fever. Antimicrob Agents Chemother 47:1727–1731PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Ternhag A, Torner A, Svensson A, Ekdahl K, Giesecke J (2008) Short–and long-term effects of bacterial gastrointestinal infections. Emerg Infect Dis 14:143–148PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Arnedo-Pena A, Beltran-Fabregat J, Vila-Pastor B, Tirado-Balaguer MD, Herrero–Carot C, Bellido-Blasco JB et al (2010) Reactive arthritis and other musculoskeletal sequelae following an outbreak of Salmonella hadar in Castellon, Spain. J Rheumatol 37:1735–1742PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Buchwald DS, Blaser MJ (1984) A review of human salmonellosis: II. Duration of excretion following infection with nontyphi Salmonella. Rev Infect Dis 6:345–356PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Corrado ML, DuPont HL, Cooperstock M, Fekety R, Murray DM (1992) Evaluation of new anti-infective drugs for the treatment of chronic carriage of Salmonella. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 15(Suppl 1):S259–262PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Gilbert DN, Moellering RC, Eliopoulis GM, Saag MS (2011) The Sanford Guide to Antimicrobial Therapy, 41st ednGoogle Scholar
  46. 46.
    Ingham B, Brentnall DW, Dale EA, McFadzean JA (1977) Arthropathy induced by antibacterial fused N-alkyl-4-pyridone-3-carboxylic acids. Toxicol Lett 1:21–26CrossRefGoogle Scholar
  47. 47.
    Adefurin A, Sammons H, Jacqz-Aigrain E, Choonara I (2011) Ciprofloxacin safety in paediatrics: a systematic review. Arch Dis Child 96:874–880PubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    Pickering LK (2009) Approach to Patients with Gastrointestinal Tract Infections and Food Poisoning. In: Feigin RD, Cherry J, Demmler-Harrison G, Kaplan S (eds). Textbook of Pediatric Infectious Diseases. Elsevier, Philadelphia, p 621–653Google Scholar
  49. 49.
    Graham SM (2008) Salmonellosis. In: McIntosh N, Helms P, Smyth R, Logan S (eds). Forfar and Arneil’s Textbook of Pediatrics, 7th edn. Elsevier, Philadelphia, p 1246–1249Google Scholar
  50. 50.
    Isaacs D (2007) Gastrointestinal infections. In: Elliot E, Gilbert R, Moyer V, Pichichero M (eds). Evidence-based Pediatric Infectious Diseases. Blackwell Publishing, United Kingdom, p 74–101CrossRefGoogle Scholar
  51. 51.
    Reller ME (2009) Salmonella Species. In: Long SS, Pickering LK, Prober C (eds). Principles and Practice of Pediatric Infectious Diseases, 3rd edn. Elsevier, Philadelphia, p 812–817Google Scholar
  52. 52.
    Bhutta ZA (2011) Salmonella. In: Kliegman RM, Stanton BMD, St Geme J, Schor N, Behrman RE (eds). Nelson Textbook of Pediatrics, 19th edn. Elsevier, Philadelphia, p 948–958CrossRefGoogle Scholar
  53. 53.
    Pickering LK (2006) Salmonella Infections. In: McMillan JA, Feigin RD, DeAngelis D, Jones MD (eds). Oski’s Pediatrics: Principles and Practice, 4th edn. Lippincott Williams and Wilkins, Philadelphia, p 1112–1116Google Scholar
  54. 54.
    Pavia AT (2011) Salmonella, Shigella, and Escherichia coli. In: Rudolph C, Rudolph A, Lister G, First L, Gershon A (eds). Rudolph’s Pediatrics, 22nd edn. McGraw Hill, New YorkGoogle Scholar
  55. 55.
    Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV et al (2001) Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 32:331–351PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    (2009) Diarrhoea and vomiting caused by gastroenteritis: diagnosis, assessment and management in children younger than 5 years. RCOG, LondonGoogle Scholar
  57. 57.
    Hohmann EL (2012) Approach to the patient with nontyphoidal Salmonella in a stool culture. In: Baron EL (ed). UpToDate, WalthamGoogle Scholar
  58. 58.
    Sirinavin S, Garner P (2000) Antibiotics for treating salmonella gut infections. Cochrane Database Syst Rev (Online):CD001167Google Scholar
  59. 59.
    Garcia de Olarte D, Hugo TS, Nancy AO, Nelson JD, Haltalin KC (1974) Treatment of Diarrhea in Malnourished Infants and Children: A Double-Blind Study Comparing Ampicillin and Placebo. Am J Dis Child 127:379–388PubMedCrossRefPubMedCentralGoogle Scholar
  60. 60.
    Nelson JD, Kusmiesz H, Jackson LH, Woodman E (1980) Treatment of Salmonella gastroenteritis with ampicillin, amoxicillin, or placebo. Pediatrics 65:1125–1130PubMedPubMedCentralGoogle Scholar
  61. 61.
    Haltalin KC, Kusmiesz HT, Hinton LV, Nelson JD (1972) Treatment of Acute Diarrhea in Outpatients: Double-Blind Study Comparing Ampicillin and Placebo. Am J Dis Child 124:554–561PubMedCrossRefPubMedCentralGoogle Scholar
  62. 62.
    Kazemi M, Gumpert TG, Marks MI (1973) A controlled trial comparing sulfametboxazole–trimethoprim, ampicillin, and no therapy in the treatment of salmonella gastroenteritis in children. J Pediatr 83:646–650PubMedCrossRefPubMedCentralGoogle Scholar
  63. 63.
    Macdonald WB, Friday F, McEacharn M (1954) The Effect of Chloramphenicol in Salmonella Enteritis of Infancy. Arch Dis Child 29:238–241PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Geme JW, 3rd, Hodes HL, Marcy SM, Pickering LK, Rodriguez WJ, McCracken GH, Jr. et al (1988) Consensus: management of Salmonella infection in the first year of life. Pediatr Infect Dis J 7:615–621PubMedCrossRefPubMedCentralGoogle Scholar
  65. 65.
    Voltersvik P, Halstensen A, Langeland N, Digranes A, Peterson LE, Rolstad T et al (2000) Eradication of non-typhoid salmonellae in acute enteritis after therapy with ofloxacin for 5 or 10 days. J Antimicrob Chemother 46:457–459PubMedCrossRefPubMedCentralGoogle Scholar
  66. 66.
    Stoycheva MV, Murdjeva MA (2006) Antimicrobial therapy of salmonelloses–current state and perspectives. Folia Med (Plovdiv) 48:5–10Google Scholar
  67. 67.
    Tsai MH, Huang YC, Lin TY, Huang YL, Kuo CC, Chiu CH (2011) Reappraisal of parenteral antimicrobial therapy for nontyphoidal Salmonella enteric infection in children. Clin Microbiol Infect 17:300–305PubMedCrossRefPubMedCentralGoogle Scholar
  68. 68.
    Onwuezobe IA, Oshun PO (2008) Antbiotics for treating nontyphoidal Salmonella diarrhoea. Cochrane Database Syst. RevGoogle Scholar
  69. 69.
    Sirinavin S, Thavornnunth J, Sakchainanont B, Bangtrakulnonth A, Chongthawonsatid S, Junumporn S (2003) Norfloxacin and azithromycin for treatment of nontyphoidal salmonella carriers. Clin Infect Dis 37:685–691PubMedCrossRefPubMedCentralGoogle Scholar
  70. 70.
    Zavala Trujillo I, Quiroz C, Gutierrez MA, Arias J, Renteria M (1991) Fluoroquinolones in the treatment of typhoid fever and the carrier state. Eur J Clin Microbiol Infect Dis 10:334–341CrossRefGoogle Scholar
  71. 71.
    Nelson MR, Shanson DC, Hawkins DA, Gazzard BG (1992) Salmonella, Campylobacter and Shigella in HIV-seropositive patients. AIDS (London, England) 6:1495–1498PubMedCrossRefPubMedCentralGoogle Scholar
  72. 72.
    Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H et al (2009) Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 58:1–207, (quiz CE1–4)PubMedPubMedCentralGoogle Scholar
  73. 73.
    Roberts C, Wilkins EG (1987) Salmonella screening of pregnant women. J Hosp Infect 10:67–72PubMedCrossRefPubMedCentralGoogle Scholar
  74. 74.
    Schloesser RL, Schaefer V, Groll AH (2004) Fatal transplacental infection with non–typhoidal Salmonella. Scand J Infect Dis 36:773–774PubMedCrossRefPubMedCentralGoogle Scholar
  75. 75.
    Cooke FJ, Ginwalla S, Hampton MD, Wain J, Ross-Russell R, Lever A et al (2009) Report of neonatal meningitis due to Salmonella enterica serotype Agona and review of breast milk-associated neonatal Salmonella infections. J Clin Microbiol 47:3045–3049PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Cahill SM, Wachsmuth K, Costarrica M, Embarek P (2008) Powdered Infant Formula as a Source of Salmonella Infection in Infants. Clin Infect Dis 46:268–273PubMedCrossRefPubMedCentralGoogle Scholar
  77. 77.
    Van Der Klooster JM, Roelofs HJ (1997) Management of Salmonella infections during pregnancy and puerperium. Neth J Med 51:83–86PubMedCrossRefPubMedCentralGoogle Scholar
  78. 78.
    Varma JK, Molbak K, Barrett TJ, Beebe JL, Jones TF, Rabatsky-Ehr T et al (2005) Antimicrobial–resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. J Infect Dis 191:554–561PubMedCrossRefPubMedCentralGoogle Scholar
  79. 79.
    Su L-H, Chiu C-H, Chu C, Ou JT (2004) Antimicrobial resistance in nontyphoid Salmonella serotypes: a global challenge. Clin Infect Dis 39:546–551PubMedCrossRefPubMedCentralGoogle Scholar
  80. 80.
    Parry CM, Threlfall EJ (2008) Antimicrobial resistance in typhoidal and nontyphoidal salmonellae. Curr Opin Infect Dis 21:531–538PubMedCrossRefPubMedCentralGoogle Scholar
  81. 81.
    Angulo FJ, Johnson KR, Tauxe RV, Cohen ML (2000) Origins and consequences of antimicrobial-resistant nontyphoidal Salmonella: implications for the use of fluoroquinolones in food animals. Microb Drug Resist (Larchmont, NY) 6:77–83CrossRefGoogle Scholar
  82. 82.
    Crump JA, Medalla FM, Joyce KW, Krueger AL, Hoekstra RM, Whichard JM et al (2011) Antimicrobial resistance among invasive nontyphoidal Salmonella enterica isolates in the United States: National Antimicrobial Resistance Monitoring System, 1996–2007. Antimicrob Agents Chemother 55:1148–1154PubMedPubMedCentralCrossRefGoogle Scholar
  83. 83.
    Meakins S, Fisher IST, Berghold C, Gerner-Smidt P, Tschape H, Cormican M et al (2008) Antimicrobial drug resistance in human nontyphoidal Salmonella isolates in Europe 2000–2004: a report from the Enter-net International Surveillance Network. Microb Drug Resist (Larchmont, NY) 14:31–35PubMedCrossRefPubMedCentralGoogle Scholar
  84. 84.
    Reddy EA, Shaw AV, Crump JA (2010) Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect Dis 10:417–432PubMedPubMedCentralCrossRefGoogle Scholar
  85. 85.
    Nordmann P, Poirel L, Mak JK, White PA, McIver CJ, Taylor P (2008) Multidrug-resistant Salmonella strains expressing emerging antibiotic resistance determinants. Clin Infect Dis 46:324–325PubMedCrossRefPubMedCentralGoogle Scholar
  86. 86.
    Miriagou V, Tzouvelekis LS, Rossiter S, Tzelepi E, Angulo FJ, Whichard JM (2003) Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob Agents Chemother 47:1297–1300PubMedPubMedCentralCrossRefGoogle Scholar
  87. 87.
    Hakanen A, Kotilainen P, Jalava J, Siitonen A, Huovinen P (1999) Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test. J Clin Microbiol 37:3572–3577PubMedPubMedCentralGoogle Scholar
  88. 88.
    Hakanen AJ, Lindgren M, Huovinen P, Jalava J, Siitonen A, Kotilainen P (2005) New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility. J Clin Microbiol 43:5775–5778PubMedPubMedCentralCrossRefGoogle Scholar
  89. 89.
    Chorba TL, Meriwether RA, Jenkins BR, Gunn RA, MacCormack JN (1987) Control of a non-foodborne outbreak of salmonellosis: day care in isolation. Am J Public Health 77:979–981PubMedPubMedCentralCrossRefGoogle Scholar
  90. 90.
    Tauxe RV, Hassan LF, Findeisen KO, Sharrar RG, Blake PA (1988) Salmonellosis in nurses: lack of transmission to patients. J Infect Dis 157:370–373PubMedCrossRefPubMedCentralGoogle Scholar
  91. 91.
    (1987) Food handlers and salmonella food poisoning Lancet 2:606–607Google Scholar
  92. 92.
    Kassis I, Dagan R, Chipman M, Alkan M, Simo A, Gorodischer R (1990) The use of prophylactic furazolidone to control a nosocomial epidemic of multiply resistant Salmonella typhimurium in pediatric wards. Pediatr Infect Dis J 9:551–555PubMedCrossRefPubMedCentralGoogle Scholar
  93. 93.
    Dyson C, Ribeiro CD, Westmoreland D (1995) Large scale use of ciprofloxacin in the control of a Salmonella outbreak in a hospital for the mentally handicapped. J Hosp Infect 29:287–296PubMedCrossRefPubMedCentralGoogle Scholar
  94. 94.
    Linnemann CC, Jr., Cannon CG, Staneck JL, McNeely BL (1985) Prolonged hospital epidemic of salmonellosis: use of trimethoprim-sulfamethoxazole for control. Infection control: IC 6:221–225PubMedCrossRefPubMedCentralGoogle Scholar
  95. 95.
    Siegel JD, Rhinehart E, Jackson M, Chiarello L (2007) Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. Healthcare Infection Control Practices Advisory Committee (HICPAC)Google Scholar
  96. 96.
    NHMRC (2010) Australian Guidelines for the Prevention and Control of Infection in Healthcare. Commonwealth of Australia 1–262Google Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Infectious Diseases UnitThe Royal Children’s Hospital MelbourneParkvilleAustralia
  2. 2.Department of PaediatricsThe University of MelbourneMelbourneAustralia
  3. 3.Infectious Diseases UnitThe Royal Children’s HospitalMelbourneAustralia
  4. 4.Infectious Diseases & Microbiology Research GroupMurdoch Children’s Research InstituteParkvilleAustralia

Personalised recommendations